Corise Opthocare M (5ml) is a prescription-only veterinary fluoroquinolone antibiotic ophthalmic solution formulated for the targeted treatment of acute and chronic bacterial eye infections in dogs and cats. The active pharmaceutical ingredient, Moxifloxacin Hydrochloride IP (0.5% w/v), is an advanced, fourth-generation broad-spectrum fluoroquinolone. It exhibits potent bactericidal activity by targeting and inhibiting two crucial bacterial enzymes: DNA gyrase and topoisomerase IV. This action halts bacterial DNA replication, transcription, and repair, leading to rapid elimination of both Gram-positive and Gram-negative ocular pathogens.

In veterinary medicine, Opthocare M is clinically indicated for treating deep-seated bacterial conjunctivitis, superficial keratitis, and blepharitis. It is also used to prevent secondary bacterial complications following corneal ulcers or accidental eye trauma. Because of its excellent corneal penetration, it reaches therapeutic concentrations within the ocular tissues much faster than older-generation antibiotics. This rapid absorption provides fast relief from common symptoms of infection, such as thick yellow-green discharge, painful squinting (blepharospasm), corneal cloudiness, and conjunctival redness. Applied topically as directed by a veterinarian, it ensures effective clearance of infection while minimizing the risk of localized bacterial resistance.